You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
廣濟藥業(000952.SZ):擬與國藥控股湖北有限公司簽署產品合作協議
格隆匯 09-03 16:45

格隆匯9月3日丨廣濟藥業(000952.SZ)公佈,公司擬與國藥控股湖北有限公司簽署《產品合作協議》,雙方着眼“原料+製劑”聯動發展戰略,本着“戰略合作、強強聯手、互惠共贏”的原則,逐步形成以原料、製劑、醫藥商業流通領域為基礎的戰略合作伙伴關係。

產品合作協議有效期自經過甲方(廣濟藥業)董事會審議通過並雙方簽字蓋章之日起20241031日止。協議合作金額為本合同期限內三個計算年度(首個計算年度為自經過甲方董事會審議通過並雙方簽字蓋章之日起至 20221031日止,後兩個計算年度均為12個月)產品銷售任務目標分別為2.8億元、3.05億元、3.3億元。

次產品合作協議的簽署,旨在以實現合作雙方的優勢互補和資源共享為目的,通過充分發揮各自的資源和優勢,共同致力於原料藥、醫藥製劑行業,有利於進一步提升公司的市場競爭力和持續盈利能力,將會給公司帶來良好的社會和經濟效益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account